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Abstract
Background: Detection of respiratory viruses in veterinary species has traditionally relied on virus detection by
isolation or immunofluorescence and/or detection of circulating antibody using ELISA or serum neutralising
antibody tests. Multiplex real time PCR is increasingly used to diagnose respiratory viruses in humans and has
proved to be superior to traditional methods. Bovine respiratory disease (BRD) is one of the most common causes
of morbidity and mortality in housed cattle and virus infections can play a major role. We describe here a one step
multiplex reverse transcriptase quantitative polymerase chain reaction (mRT-qPCR) to detect the viruses commonly
implicated in BRD.
Results: A mRT-qPCR assay was developed and optimised for the simultaneous detection of bovine respiratory
syncytial virus (BRSV), bovine herpes virus type 1 (BoHV-1) and bovine parainfluenza virus type 3 (BPI3 i & ii) nucleic
acids in clinical samples from cattle. The assay targets the highly conserved glycoprotein B gene of BoHV-1,
nucleocapsid gene of BRSV and nucleoprotein gene of BPI3. This mRT-qPCR assay was assessed for sensitivity,
specificity and repeatability using in vitro transcribed RNA and recent field isolates. For clinical validation, 541
samples from clinically affected animals were tested and mRT-qPCR result compared to those obtained by
conventional testing using virus isolation (VI) and/or indirect fluorescent antibody test (IFAT).
Conclusions: The mRT-qPCR assay was rapid, highly repeatable, specific and had a sensitivity of 97% in detecting
102 copies of BRSV, BoHV-1 and BPI3 i & ii. This is the first mRT-qPCR developed to detect the three primary viral
agents of BRD and the first multiplex designed using locked nucleic acid (LNA), minor groove binding (MGB) and
TaqMan probes in one reaction mix. This test was more sensitive than both VI and IFAT and can replace the
aforesaid methods for virus detection during outbreaks of BRD.
Background
Bovine respiratory disease (BRD) is a major disease pro-
blem for the cattle industry, causing huge economic
losses; research on BRD has been a longstanding global
priority. While the aetiology is multifactorial, infectious
agents are important in the development of disease. The
important infectious causes of BRD include viruses, bac-
teria and mycoplasma [1,2]. Aside of infectious causes,
stress and environmental factors such as weaning, tem-
perature, stocking density, dust, humidity, transportation
and inadequate nutrition are also important co-factors
in development of disease [3]. In economic terms, BRD
leads to decreased production, higher levels of mortality
and morbidity, increased veterinary and labour costs
and reduced carcass value [4-6].
The primary viral respiratory pathogens are bovine
herpesvirus-1 (BoHV-1, also known as bovine infec-
tious rhinotracheitis virus), bovine respiratory syncytial
virus (BRSV), and bovine parainfluenza type 3 (BPI3)
[1,2]. While usually considered a respiratory pathogen,
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infection with BoHV-1 can also cause abortion in
pregnant cattle [7]. Infection with these viruses can
also facilitate invasion of opportunistic secondary
pathogens such as Mannheimia haemolytica, Pasteur-
ella multocida, Haemophilus somni and a number of
mycoplasma species such as M. bovis and M. dispar
[1,2,8]. On farms where bovine viral diarrhoea virus
[BVDV] is not well controlled, this can lead to immu-
nosuppression and influence the progression of BRD.
Permanent lung damage can result following an epi-
sode of BRD, making animals more susceptible to sub-
sequent episodes of respiratory disease compromising
growth rates and economic returns for the farmer
[4,9,10].
Irrespective of the infectious agent involved, the pre-
senting clinical signs of BRD can appear similar. More-
over, the detection of bacterial pathogen can mask an
underlying viral cause; virus isolation may not always be
successful and alternative methods of detection like
IFAT can lack sensitivity and specificity compared to
molecular detection methods. Single target (mono-speci-
fic) PCR assays require separate amplification of each
target and can be expensive, inefficient and resource
intensive where multiple pathogen detection is neces-
sary. In this scenario, multiplex PCR has a significant
advantage, as it permits simultaneous detection of sev-
eral viruses in a single reaction mixture, facilitating
cost-effective diagnosis [11]. Real time PCR can provide
rapid results for the clinical virologist with a reduced
risk of contamination, and can detect, differentiate and
provide a quantitative result for many different targets
without any single target influencing the detection of
the others [12,13].
The aim of this study was to develop a simple, sensi-
tive, specific, rapid and cost effective mRT-qPCR
method for the detection of BRSV, BoHV-1 and BPI3 in
clinical samples. The assay was compared to the con-
ventional methods of virus isolation and FAT to assess
its application in routine diagnosis of the aetiological
agents involved in BRD.
Results
Integrity of clinical material
A b-actin signal was detected in all clinical samples
tested in the mRT-qPCR indicating no evidence of
extraction failure or PCR inhibition.
Specificity of the mRT-qPCR
The performance of the mRT-qPCR on the virus panel
demonstrated neither non-specific reactions nor any
inter-assay cross amplification. On well characterised
archived isolates for each of the viruses (Table 1), only
the intended target virus was amplified by the mRT-
qPCR.
Sensitivity of the mRT-qPCR
A ten-fold serial dilution of each of the in vitro tran-
scribed RNAs was tested in triplicate and the mRT-
qPCR assay compared to the same template using the
mono-specific assay; similar Cp values were obtained for
both formats. The standard curves obtained from the
mRT-qPCR and mono-specific assay are shown in Fig-
ure 1 A, B, C, D. There was no appreciable difference in
the mean Cp values of the mono-specific assay and the
mRT-qPCR assay for BoHV-1, BRSV and BPI3. The
estimates of Cp values (95% lower, upper confidence
intervals) that corresponds to 97% diagnostic test sensi-
tivity conditional on virus copy numbers and test meth-
ods for each virus are presented in Table 2. As observed
for the standard curve, the Cp values for the mono-spe-
cific assay and the mRT-qPCR assays were very similar
and hence both assays may be regarded as equally sensi-
tive for diagnostic purpose. These results confirmed that
the mRT-qPCR could achieve sensitivity of 97% with Cp
values in the range of 31-33 when the samples included
103 viral genome copy numbers for all targets; a similar
sensitivity was shown with Cp values in the range of 34-
35 for 102 viral genome copy numbers. Moreover, the
efficiency of the PCR reaction and the detection limits
of each target virus were not compromised by multi-
plexing the reaction (Table 3).
Simultaneous detection of multiple virus targets
The template mixture of ten-fold serial dilutions of the
four in vitro transcribed virus targets was tested in tripli-
cate by mRT-qPCR assay. All four targets were detected
and no evidence of cross reactivity between primers and
probes or any reduction in sensitivity was observed.
Analysis of clinical samples
The performance of the mRT-qPCR assay in clinical
material was evaluated on several different sample types
Table 1 Different isolates of BRSV, BoHV-1 and BPI3
tested in this study
BRSV BoHV-1 BPI3 i BPI3 ii
A4446/A 6660 N3322 A2084
A4644/3 Naselgen L3380 J2365
B446/A Tracherine L3047/1 A2112
B4332/1 Aberdeen B2279/3 B788
B4332/2 Oxford
B4446/A Stricken
B4596/1
B4596/3
B4596/4
D4636/1
D4658/7
R4017/5
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including swabs, fresh and fixed tissues and bronchoal-
veolar lavage samples; further, a small number of tissue
culture supernatants (n = 15) derived from clinical sam-
ples were included (total samples tested = 541; see
Table 4 for sample detail). Results of IFAT and virus
isolation were not available for all 541 samples. This is
because the testing was targeted depending upon the
decisions made by individual private veterinary surgeons
and diagnosticians at external veterinary laboratories
submitting the material. IFAT was performed on 214
samples for BoHV-1, 222 samples for BRSV and 106
samples for BPI3. Virus isolation was carried out on 80
samples.
BoHV-1 nucleic acid was detected as a single agent by
the mRT-qPCR in 48/541 samples, BRSV RNA in 28/
541 samples and BPI3 i RNA in 14/541 samples; co-
infection with BoHV-1 and BPI3 i was observed in 3
samples. While BPI3 ii had been detected previously, it
was not identified during this study period.
Of the 48 samples in which BoHV-1 nucleic acids
were detected, BoHV-1 was also identified in 23 by
IFAT. BoHV-1 was isolated from 12 samples, including
8 samples positive by IFAT; in 4 samples BoHV-1 was
isolated but not detected by IFAT. In addition, IFAT
detected BoHV-1 in 3 samples where BoHV-1 was not
detected by the mRT-qPCR or by virus isolation; this
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Figure 1 Comparison of the standard curves of the uniplex and multiplex real time RT-PCR assay for the detection of (A) BoHV-1, (B)
BRSV, (C) BPI3 i and (D) BPI3 ii.
Table 2 Estimates (95% lower, upper confidence levels)
of mean cut-off Cp values after amplification of a
dilution of titrated virus in uniplex and multiplex real
time RT-PCR for a test sensitivity of 97%a
Mean Cut-off Cp value
Virus Copy number Uniplex RTPCR Multiplex RTPCR
BRSV 103 32.9 (32.1, 33.6) 33.0 (32.2, 33.7)
102 35.4 (34.5, 36.1) 35.4 (34.6, 36.1)
10 37.7 (36.8, 38.5) 37.7 (36.9, 38.5)
BoHV-1 103 31.4 (31.0, 31.9) 31.4 (31.0, 31.9)
102 35.2 (34.8, 35.8) 35.2 (34.8, 35.8)
10 37.1 (36.6, 37.6) 37.1 (36.6, 37.6)
BPI3 i 103 31.7 (31.2, 32.4) 32.5 (31.9, 33.1)
102 34.4 (33.9, 35.1) 35.2 (34.6, 35.8)
10 39.4 (39.0, 40.2) 40.2 (39.7, 41.0)
BPI3 ii 103 32.4 (32.2, 32.8) 32.8 (32.6, 33.1)
102 34.7 (34.4, 35.0) 35.1 (34.9, 35.4)
10 38.4 (38.2, 38.8) 38.9 (38.7, 39.2)
a For each virus, a 10-fold dilution series is shown with the mean Cp values.
The lowest level of detection is shown, as are the two 10-fold dilutions
immediately prior to the lowest level of detection. Each dilution series was
tested four times in triplicate. The estimates of the mean cut-off Cp value for
a test sensitivity of 97% and corresponding 95% confidence intervals were
obtained using a bootstrap sampling procedure (see text for detail).
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likely indicates poorer specificity of the IFAT for BoHV-
1. BoHV-1 was not detected in the remaining samples
tested by either IFAT (n = 188) or virus isolation (n =
68).
Of the 28 samples in which BRSV RNA was detected,
BRSV was detected in eight samples by FAT; BRSV was
not detected by virus isolation in any sample. BRSV is
difficult to detect by virus isolation as infectivity is
rapidly lost outside the host. BRSV was not detected in
any of the remaining samples by FAT (n = 214).
Of the 14 samples in which BPI3i RNA was detected,
BPI3 was detected in 3 by virus isolation; but in none of
the 106 samples tested by IFAT.
Repeatability
The estimates of repeatability standard deviation (SDr)
and relative standard deviation of repeatability (RSDr) of
uniplex and multiplex assays for different viruses are
presented in Table 5. The multiplex assay showed
slightly higher estimates of SDr and RSDr than the uni-
plex assay for all viruses. The estimates of SDr in uni-
plex assays ranged from 0.39 to 0.58 while for multiplex
assays they ranged from 0.70 to 1.30. The estimates of
RSDr (%) ranged from 1.04 to 1.50 and 1.79 to 3.40 for
uniplex and multiplex assays respectively. In general,
estimates of SDr and RSDr for both assays were within
the acceptable range of a standard diagnostic test (Table
5).
To further investigate the reproducibility and perfor-
mance of this assay on clinical materials, twenty positive
and negative samples each for BRSV and BoHV-1 and
fourteen positive and negative samples of BPI3 i by mul-
tiplex assay were randomly selected. These samples were
re-tested in parallel by both mono-specific and mRT-
qPCR assays. Both assay formats identified the appropri-
ate target and the results matched the original mRT-
qPCR test result.
Discussion
The mRT-qPCR is a rapid and efficient method for the
detection and differentiation of BRSV, BoHV-1 and
BPI3 and is thus an invaluable tool in the aetiological
resolution of BRD. Aside of multiple pathogen detection,
the assay has several advantages over conventional
methods including higher sensitivity and specificity,
decreased cost, smaller sample size, rapidity of proces-
sing and the possibility of laboratory automation to suit
high throughput veterinary diagnostic laboratories. The
multiplex format showed complete concordance with
the corresponding mono-specific RT-PCRs. The applica-
tion of mRT-qPCR for the detection of multiple patho-
gens provides a major contribution to efficiency,
Table 3 Detection limits and efficiencies of the multiplex and uniplex RT-QPCRs
Virus Detection limit (copy no. per μl) Reaction efficiency
Multiplex Uniplex Multiplex Uniplex
BoHV-1 101 101 2.01 1.99
BRSV 101 101 2.14 2.00
BPI3 i 102 102 1.92 1.99
BPI3 ii 102 102 2.09 2.03
Table 4 Multiplex real time RT-PCR results for 541 clinical samples
Clinical material Number of samples tested BoHV-1 detected BRSV detected BPI3 detected
Liver (fetal) 189 2 0 0
BAL 19 4 0 2
Swab 136 27 14 4
Lung 106 5 10 7
Spleen 9 1 0 0
Placenta 32 2 0 0
Fetal fluid 7 0 0 0
Trachea 19 6 1 1
Cell culture 15 1 3 0
Oesophagus 1 0 0 0
Tonsil 1 0 0 0
Brain 1 0 0 0
Wax blocks 6 0 0 0
A list of clinical material positive for BRSV, BPI3 and BoHV-1 is shown.
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logistics, and cost-effectiveness of molecular diagnostics
[14-18].
A multiplex real time RT-PCR has been reported pre-
viously for BVDV (5’UTR), BoHV-1 (glycoprotein C)
and BPI3 (matrix) [18]. While BVDV can be important
in the development of BRD, BRSV is a primary patho-
gen and is thus included in the mRT-qPCR described
herein. The use of shorter length MGB and LNA probes
is advantageous, typically confering stability, target spe-
cificity, greater sensitivity and discrimination for the tar-
get gene [19].
As co-infections are a regular feature of BRD in field
outbreaks [1,2,10,20], careful optimisation is required to
ensure that the molecular diagnostic test employed will
not detect one target virus preferentially. Primers and
probes for multiplex assays should be assessed both in
silico and in vitro for evidence of cross amplification,
competition or inhibition. The mRT-qPCR assay
described here can detect viral co-infections both in
technical validation experiments and in clinical samples.
No cross reactivity between primers and probes was
observed, nor was a reduction in sensitivity detected.
The sensitivity of the multiplex and uniplex assay was
evaluated by testing 10-fold serial dilutions of in vitro
transcribed RNAs for BRSV, BoHV-1 and BPI3 i and ii.
The sensitivity, efficiency and detection limits of the
individual RT-qPCRs were not affected by multiplexing
the reactions. The standard curves and reaction efficien-
cies were very similar for the mRT-qPCR and mono-
specific reactions (Figure 1 A, B, C, D; Table 3). A per-
fect amplification reaction has an efficiency of 2, but in
reality, reactions often have efficiencies of less than2;
the acceptable range is considered to be between 1.7
and 2.2 [21]. The efficiencies obtained for both assays in
this study were within this range.
For BRSV and BPI3, all samples in which these
viruses were detected by other methods were detected
by the mRT-qPCR. Additionally, the mRT-qPCR iden-
tified BRSV and BPI3i in 20 and 14 additional samples
respectively, suggesting a higher sensitivity. For BoHV-
1, this was the case for virus isolation and for the
majority of FAT positive samples. However, three sam-
ples were positive on BoHV-1 FAT but negative on
both virus isolation and mRT-qPCR; this suggests a
lack of specificity in the FAT; further, the mRT-PCR
identified BoHV-1 in 25 additional samples when com-
pared to FAT results, suggesting higher sensitivity. The
mRT-qPCR also detected dual infections (BoHV-1 and
BPI3 i) in three samples; in virus isolation of these
samples, BoHV-1 overgrew BPI3, masking detection.
These results demonstrate that the m RT-qPCR is
more specific and sensitive in respiratory viral diagno-
sis when compared to conventional tests, as has been
shown in both veterinary and human clinical pathology
settings [16,22-25].
False negative results can occur due to RT- PCR
inhibition, which was controlled in this sample set by
the use of an endogenous internal control (b-actin).
While this assay was run separately, it would be possi-
ble to consider including this control in the multiplex
reaction by, for example, labelling both subgenotypes
of BPI3 with the same fluorophore. The selection of
target sequences is also critical factor that can contri-
bute to false negatives; it is possible (especially for
RNA viruses, due to the higher error rate of RNA
polymerases) that mutations in the primer and probe
regions may occur which compromise molecular detec-
tion at the target site (25). While sequences for mole-
cular assays are selected in silico to ensure the target
region is highly conserved, unusual or unexpected
results from clinical samples should always trigger
further investigation by either conventional methods or
use of molecular assays with different target sequences
or degenerate primers.
A final advantage of the use of molecular based testing
in a clinical setting is the ability to include other targets
e.g. as adenovirus, BVDV and bacterial pathogens. The
limitations of real time PCR based multiplex detection
and differentiation rest with the number of reactions
which can be optimised in a single tube and the number
of fluorophores which can be simultaneously detected.
While real time PCR platforms can generally detect no
more than 5 fluorophores, labelling strategies can be
used to increase the number of targets detected and the
development of fluorophore labelled bead based detec-
tion systems (e.g. Luminex assays) may extend target
detection. Currently, the aetiology of many BRD out-
breaks is undiagnosed, in some part due to the range of
respiratory pathogens which must be sought and the
cost of multiple pathogen detection by mono-specific
assays. Adding further pathogen targets to molecular
assays should improve aetiologic identification in inves-
tigation of BRD.
Table 5 Estimates (95% lower, upper confidence levels)
of standard deviation (SDr) and relative standard
deviation (RSDr) of repeatability of uniplex and mRT-
qPCR assays
Virus Uniplex Multiplex
SDr RSDr (%) SDr RSDr (%)
BoHV-1 0.39
(0.31, 0.49)
1.04
(0.82, 1.31)
1.15
(0.94, 1.41)
3.10
(2.53, 3.79)
BRSV 0.46
(0.36, 0.59)
1.26
(0.99, 1.60)
1.30
(1.10, 1.53)
3.40
(2.88, 4.02)
BPI3-i 0.58
(0.29, 1.17)
1.50
(0.75, 3.00)
0.70
(0.59, 0.83)
1.79
(1.50, 2.13)
BPI3-ii 0.57
(0.43, 0.75)
1.36
(1.03, 1.80)
0.86
(0.71, 1.04)
2.07
(1.71, 2.50)
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Conclusions
In conclusion, this mRT-qPCR assay is a sensitive and
specific technique capable of detection of three major
viral respiratory pathogens of cattle, and may have addi-
tional benefit when more than one agent is involved.
Although reagents for multiplex and real time PCR
assays are traditionally considered expensive, the ability
to perform these assays within a short time frame to
detect multiple pathogens reduces hands-on time in the
laboratory, is more efficient and can generate valuable
information in differential diagnosis. Additional cost
benefits on farm will result from more rapid diagnosis
and the ability to target treatment, use appropriate vac-
cines or implement improved management procedures
quickly.
Methods
Viruses
The viral strains used in this study included isolates of
BRSV, BoHV-1, and BPI3 i & ii. A vaccine isolate of
BRSV (Rispoval RS, Pfizer Ltd) was used for assay opti-
misation and eight other BRSV isolates were used for
preliminary validation experiments [22,26]. A reference
strain of BoHV-1 (6660) was used for the initial optimi-
sation of assay and further five isolates were tested for
validation purposes [27]. Preliminary amplification and
sequencing studies targeting fusion protein region and
nucleoprotein region of 15 BPI3 UK isolates identified
two distinct genotypes as has been previously described
elsewhere [28]. Our observations suggest that the substi-
tutions are largely non-synonymous, suggesting the
sequence variation is likely to be of limited antigenic or
clinical significance (data not shown; representative of
BPI3i and BPI3ii sequences deposited with Genbank as
JQ627625 and JQ627626 respectively). As the gene
regions targeted in the current assay were not assigned
to the BPI3 genotypes in the sequence databases at the
time of assay design they are referred to herein as BPI3
i & ii. Two clinical isolates L3380 (BPI3 i) and A2112
(BPI3 ii) were used for optimisation of the assay. A
further three isolates each of BPI3 i and ii strains were
used for preliminary validation. The various viruses used
for technical validation of the mRT-qPCR are shown in
Table 1.
Respiratory viral culture
Samples were processed in primary bovine embryonic
kidney cells (BEK) using standard methods. Briefly, the
tissues were homogenised using a gentleMACS dissocia-
tor with M tubes (both Miltenyi Biotec Ltd. Surrey, UK)
in virus transport medium (VTM; Hanks balanced salt
solution containing 0.02% phenol red, 1% w/v bovine
albumin, 0.45 w/v sodium hydrogen carbonate, 600 u/
ml benzyl penicillin, 0.3 mg/ml streptomycin sulphate,
50 u/ml polymyxin B and 50 u/ml nystatin), centrifuged
at 2,000 × g for 10 min at 4°C, filtered through 0.45 nm
filter and the supernatant was harvested for inoculating
primary bovine embryo kidney (BEK) cell culture. For
respiratory swabs and bronchoalveolar lavage (BAL)
samples in VTM, the entire sample was sonicated for 30
s, filtered through 0.45 nm filter and the supernatant
was harvested for inoculation. 200 μl of each sample
was added to cell cultures maintained in tubes, incu-
bated at 37°C, 5% CO2 and observed for the develop-
ment of cytopathic effect (CPE) for 5-7 days. Two
passages were routinely performed.
mRT-qPCR specificity
The specificity of the mRT-qPCR was assessed by test-
ing viral nucleic acid extracted from a range of veterin-
ary viruses, which had been maintained in cell culture
and validated in other diagnostic tests, comprising bor-
der disease virus, bovine viral diarrhoea virus, bovine
adenovirus, ovine adenovirus, canine distemper virus,
bovine herpesvirus 2, 4 and 6, alcelaphine herpesvirus 1,
ovine parvovirus, ovine reovirus, Semliki forest virus and
orf virus. Additionally, the closely related viruses human
respiratory syncytial virus (a gift from the late Prof. C.A.
Hart, University of Liverpool) and avian metapneumo-
virus (a gift from Prof R.C. Jones, University of Liver-
pool) were included in specificity testing.
Clinical samples
From December 2009 to April 2011, 541 clinical sam-
ples from respiratory or abortion material (136 swabs,
19 BALs, 106 lung, 189 foetal liver, 9 spleen, 32 pla-
centa, 19 trachea, 1 brain, 1 oesophagus, 1 tonsil, 7 foe-
tal fluids, 6 formalin fixed paraffin embedded [FFPE]
tissues and 15 cell culture supernatants) were tested by
routine diagnostic tests for respiratory viruses. An ali-
quot from each sample was stored at -80°C for later
mRT-qPCR analysis.
RNA extraction
Total sample RNA was extracted using commercial kits
as appropriate to the sample type; QIAamp Viral RNA
Mini spin protocol (Qiagen, Crawley, UK) was used for
samples of low cellularity (swabs and BALs), RNeasy
Mini kit (Qiagen, Crawley, UK) was used for fresh or
frozen tissue samples and RecoverAll™ Total Nucleic
Acid Isolation Kit (Applied Biosystems, Warrington,
UK) was used for FFPE sections. All methods were used
as per the manufacturer’s instructions. We have pre-
viously demonstrated that the QIAamp Viral RNA kit
co-purifies BoHV-1 DNA from low cellularity samples
[29] and, as BoHV-1 produces viral RNA during
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replication in tissues, for simplicity of clinical sample
preparation we did not explicitly extract DNA for
BoHV-1 detection. Phosphate buffered saline (PBS) was
used as an extraction control for all extraction methods.
All nucleic acid extractions were stored at -80°C prior
to testing.
Preparation of RNA controls
Plasmids containing the mRT-qPCR target sequences for
BRSV, BPI3 and BoHV-1 were produced using the
TOPO TA cloning kit (Invitrogen) and RNA transcribed
in vitro (Riboprobe system, Promega) according to man-
ufacturers’ protocols. RNA quality and integrity was
confirmed using a RNA NanoLabChip on an Agilent
2100 Bio analyser (Agilent Technologies) and used to
construct standard curves from 100 to 1010 copies. All
samples had an RNA integrity number greater than 9.
Primers, probes and mRT-qPCR
The primer and probe sequences, fluorophores and
quenchers used are shown in Table 6[22,30]. As appro-
priate fluorophore combinations could not be designed
using MGB probes to allow multiplexing with four col-
our detection, the reporter dyes were altered and the
BRSV probe was modified to replace the minor groove
binding (MGB) modification by locked nucleic acids
(LNA). A b-actin primer and probe set was also used in
a separate mono-specific assay to assess sample integrity
and mRT-qPCR inhibition.
mRT-qPCR conditions
Optimisation of the mRT-qPCR included prior assess-
ment of the mono-specific assays, testing several master
mix reagent sets, titration of primer and probe concen-
trations and alteration of RT and PCR cycling para-
meters. Quantifast Multiplex RT-PCR (Qiagen, Crawley,
UK) was chosen as the optimum reagent for mRT-
qPCR. Reactions were performed in triplicate on 96 well
plates (Lightcycler 480 multiwell plate 96, Roche UK) in
a total volume of 25 μl containing a final concentration
of 200 nM each primer and 100 nM each probe and 1
μl of template RNA. The b-actin mono-specific RT-PCR
was performed in a similar manner except that final pri-
mer and probe concentrations were 500 nM and 200
nM respectively.
All reactions performed on a Light Cycler 480 II
(Roche UK) with the following cycling parameters; 50°C
for 20 min (RT) and 95°C for 2 min (hot start), 40
cycles of 95°C for 15 s (denaturation) and 60°C for 1
min (annealing/extension), followed by a final stage of
40°C for 10 s (cooling). The results were analysed using
Light Cycler 480 SW1.5 software (Roche UK). For each
amplification plot, a crossing point value (Cp), repre-
senting the PCR cycle number at which the reporter dye
fluorescence was detectable above the background fluor-
escence, was calculated automatically using the ‘2nd
derivative max’ method. Cross-talk was eliminated
almost entirely by applying colour compensation as per
the protocol provided by the instrument manufacturer
(Roche UK); the use of the four fluorophores allowed
differentiation of the virus targets.
Simultaneous detection of multiple virus targets
A template mix including ten-fold serial dilution of the
four in vitro transcribed virus targets was tested.
Statistical analysis
A linear mixed model was fitted to the observed Cp
values of each virus. The day of experiment was fitted
as a random effect while the logarithm (base 10) of viral
copy number and its polynomial terms (quadratic and
cubic), RT-PCR method (two levels: uniplex and multi-
plex), and the interaction effect of RT-PCR method and
log viral copy number were fitted as fixed effects. The
heterogeneity of variance due to different levels of viral
copy number was also considered. The estimates of var-
iance were obtained using the restricted maximum like-
lihood (REML) method. Only fixed main effects and
interaction terms that were statistically significant (P ≤
Table 6 Primers and probes for multiplex real-time RT-
PCRa
Viruses Primers/probes Sequences (5’-3’)
BPI3 i BPI3euro
Forward
GGTAGGAGCACCTCCACGATT
BPI3euro Reverse GCTCCAAGGCATGCTGGATA
BPI3euroMGB VIC-AAGATCTTGTTCACACATTC-MGB-NFQ
BPI3 ii BPI3 Forward2 TGATTGGATGTTCGGGAGTGA
BPI3Reverse2 AGAATCCTTTCCTCAATCCTGATATACT
BPI3Fam FAM-TACAATCGAGGATCTTGTTCA-MGB-
NFQ
BRSV [14] BRSVn Forward GGTCAAACTAAATGACACTTTCAACAAG
BRSVn Reverse AGCATACCACACAACTTATTGAGATG
BRSVLNACyan500 Cyan500-TAGTACAGGTGACAA+CA+T
+TG-BBQ
BoHV-1
[15]
gB Forward TGTGGACCTAAACCTCACGGT
gB Reverse GTAGTCGAGCAGACCCGTGTC
gBCy5 Cy5-AGGACCGCGAGTTCTTGCCGC-BHQ2
b-actin Bac1F_uni GACAGGATGCAGAARGAGATCAC
Bac2R_uni TCCACATCTGCTGGAAGGTG
b-actin FAM-
MGB
FAM-TGAAGATCAAGATCATCG-MGB-NFQ
a All the primers and probes are obtained from Applied Biosystems
(Warrington, UK) except BRSV LNAcyan500 probe (TIB Molbiol,Berlin, Germany)
and gBCy5 probe (Eurofins MWG Operon, Germany).
Abbreviations: BHQ black hole quencher, MGB-NFQ minor groove binding-non
fluorescent quencher, LNA locked nucleic acid, BBQ Blackberry quencher.
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0.05) were retained in the final model. Standard model
assumptions of normality and independence of error
terms were also assessed. The estimates of means and
variance components obtained from the final fitted
model were then used to quantify the statistical proper-
ties of Cp estimates using a parametric bootstrap sam-
pling process [31]. For each virus and choice of log copy
number, the model fitted to the original data was used
to generate a total of 1000 random pseudo-test samples
within each bootstrap cycle, and the bootstrap process
was repeated 10,000 times. The outcomes of all simu-
lated data were used to estimate the mean cut-off value
of Cp that equates to 97% sensitivity for the diagnostic
test for each specific virus, conditional on the log viral
copy number and the RT-PCR method, while 95% confi-
dence intervals for these estimates were calculated using
10,000-term bootstrap distribution of each quantity.
Estimates of repeatability standard deviation (SDr) and
relative standard deviation (RSDr) for each assay were
calculated as suggested by Horwitz [32]. To estimate the
repeatability of an assay for each virus, linear models
were fitted to the uniplex and multiplex assay data sepa-
rately. The estimates of SDr and corresponding 95%
confidence intervals for each assay were obtained from
the estimate of residual standard deviation of the model.
The estimate of RSDr (or coefficient of variation) of
repeatability was obtained as the ratio of SDr to mean
and expressed as a percentage. All statistical analyses
were carried out using R software version 2.13.1 [33].
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